期刊文献+

色谱-质谱联用技术研究盐酸西那卡塞的有关物质 被引量:5

Studies on related substances in cinacalcet hydrochloride by LC-MS
下载PDF
导出
摘要 采用LC-MS法分离和鉴定盐酸西那卡塞有关物质。采用Hypersil C_(18)(100 mm×4.6 mm,2.4μm)色谱柱,以0.1%乙酸铵溶液-乙腈(93∶7)为流动相A相,乙腈为流动相B相进行线性梯度洗脱,对盐酸西那卡塞有关物质及强制降解产物进行分离。经过电喷雾正离子化-高分辨TOF/MS检测,同时结合MS/MS光谱和对照品对照,对各有关物质进行分析鉴定。在所建立的液-质联用分析条件下,盐酸西那卡塞及其有关物质得到有效的分离,共检测到10个有关物质,分别为盐酸西那卡塞合成起始原料(1个)、合成中间体(1个)、合成副产物(4个)和降解产物(5个)。建立的LC-MS法能有效鉴定盐酸西那卡塞有关物质,并为其质量控制和工艺优化研究提供参考依据。 To develop an LC-MS method for the separation and identification of the related substances in cinacalcet hydrochloride. The separation was carried out on a Thermo BDS Hypersil C18 column(100 mm×4. 6 mm, 2. 4 μm)with mobile phase consisting of 0. 1% ammonium acetate buffer-acetonitrile(93∶7)(A)and acetonitrile(B)by gradient elution. The related substances were identified by electrospray positive ionization high resolution TOF/MS and MS/MS, and verified further through reference substances. Cinacalcet hydrochloride and itsrelated substances were separated under the established LC-MS condition. Ten related substances were detected and identified to be one starting material, one intermediate, four synthetic by-products and five degradation products. It showed that the LC-MS method was useful for separating and identifying the related substances in cinacalcet hydrochloride. And the results obtained are valuable for cinacalcet hydrochloride manufacturing process control and quality assurance.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2016年第6期719-726,共8页 Journal of China Pharmaceutical University
关键词 盐酸西那卡塞 有关物质 结构鉴定 色谱-质谱联用 cinacalcet hydrochloride related substance structure identification LC-MS
  • 相关文献

参考文献5

二级参考文献26

  • 1燕宇.西那卡塞的临床应用以及研究进展[J].中国血液净化,2012,11(8):460-463. 被引量:23
  • 2Nemeth EF,Steffey ME,Hammerland LG,et al.Calcimimetics with potent and selective activity on the parathyroid calcium receptor[J].Proc Natl Acad Sci U S A,1998,95(7):4040-4045. 被引量:1
  • 3Nemeth EF,Heaton WH,Miller M,et al.Pharmacodynamics of the type Ⅱ calcimimetic compounds cinacalcet HCI[J].J Pharmacol Exp Ther,2004,308 (2):627-635. 被引量:1
  • 4Nemeth EE Van Wagenen BC,Balandrin MF,et al.Calcium receptor-active molecules:US,6011068[P].2000-01-04. 被引量:1
  • 5Van Wagenen BC,Moe ST,Balandrin ME et al.Calcium receptor-active compounds:US,6211244[P].2001-04-03. 被引量:1
  • 6Thiel OR,Bernard C,Tormos W,et al.Practical synthesis of the calcimimetic agent,cinacalcet[J].Tetrahedron Lett,2008,49(1):13-15. 被引量:1
  • 7Bijukumar G,Maloyesh B,Bhaskar BS,et al.Efficient synthesis of cinacalcet hydrochloride[J].Synth Commun,2008,38(10):1512-1517. 被引量:1
  • 8Lifshitz-liron R,Eisenstadt A,Wizel S,et al.Process for preparing cinacalcet hydrochloride:WO,2006125026[P].2006-11-23. 被引量:1
  • 9NAGANO N. Pharmacological and clinical properties of calcimimetics: Calcium receptor activations that afford an innovative ap- proach to controlling hyperparathyroidism [J]. Pharmacol Ther, 2006, 109(3): 339-365. 被引量:1
  • 10NEMETH EF, HEATON WH, MILLER M, et al. Pharmacodynamics of the type Ⅱ calcimimetic compound cinacalcet HCI[J]. J Pharmacol Exp Ther, 2004, 308 (2) :627 - 635. 被引量:1

共引文献24

同被引文献34

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部